Glean’s most recent official valuation stands at $7.2 billion from its $150 million Series F in mid-2025, while secondary-market marks have eased to roughly $6.3–6.9 billion as of October 2026. Strong revenue momentum—$300 million ARR reached by May 2026 after tripling in 15 months—supports the prior mark, yet the company has signaled no plans for additional equity raises or an imminent IPO. Traders therefore focus on whether continued enterprise adoption, margin expansion, or broader AI risk appetite can lift secondary prices or trigger a new primary round before year-end, versus ongoing multiple compression in private AI names and limited near-term catalysts.